يعرض 1 - 10 نتائج من 12 نتيجة بحث عن '"Muñoz-Couselo, Eva"', وقت الاستعلام: 0.96s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Remon J Paris-Saclay University, Department of Cancer Medicine, Gustave Roussy, Villejuif. Auclin E Department of Cancer Medicine, Hôpital Européen Georges-Pompidou, Paris, France. Zubiri L Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, USA. Schneider S Department Pneumology, Hôpital de Bayonne, Bayonne, France. Rodriguez-Abreu D Medical Oncology Department, Complejo Hospitalario Universitario Insular-Materno Infantil de Gran Canaria, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain. Minatta N Department of Oncology Hospital Italiano Buenos Aires, Buenos Aires, Argentina. Muñoz-Couselo E Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: ESMO Open;9(5); https://doi.org/10.1016/j.esmoop.2024.103004Test; Remon J, Auclin E, Zubiri L, Schneider S, Rodriguez-Abreu D, Minatta N, et al. Immune checkpoint blockers in solid organ transplant recipients and cancer: the INNOVATED cohort. ESMO Open. 2024 Apr 22;9(5):103004.; https://hdl.handle.net/11351/11393Test

  2. 2
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, González-Cruz C, García-Patos V, Ferrándiz-Pulido C Servei de Dermatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Facultat de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Muñoz-Couselo E, Ortiz-Velez C Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona Spain. Vall d’Hebron Institute of Oncology (VHIO), Biblioteca, Spain. Ferrer B Servei d’Anatomia Patològica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: JAAD Case Reports;46; https://doi.org/10.1016/j.jdcr.2024.02.011Test; González-Cruz C, Muñoz-Couselo E, Ortiz-Velez C, Ferrer Fàbrega B, García-Patos Briones V, Ferrándiz-Pulido C. Complete response of metastatic cutaneous squamous cell carcinoma and multiple locally advanced basal cell carcinomas with concomitant pembrolizumab and sonidegib therapy. JAAD Case Reports. 2024 Mar 1;46:67–9.; https://hdl.handle.net/11351/11307Test

  3. 3
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Mandalà M Unit of Medical Oncology, University of Perugia, Perugia, Italy. Lorigan P, Serra P The University of Manchester, Oxford Rd, Manchester M13 9PL, UK. Sergi MC Medical Oncology Unit, Azienda Ospedaliero Universitaria Policlinico di Bari, Bari, Italy. Benannoune N Gustave Roussy Cancer Campus, Villejuif, France. Vitale MG Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, I.N.T. IRCCS Fondazione "G. Pascale" Napoli, Naples, Italy. Munoz Couselo E Servei d’Oncologia Mèdica, Vall d′Hebron Hospital, Barcelona, Spain. Vall d′Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: European Journal of Cancer;199; https://doi.org/10.1016/j.ejca.2024.113542Test; Mandalà M, Lorigan P, Sergi MC, Benannoune N, Serra P, Vitale MG, et al. Combined immunotherapy in melanoma patients with brain metastases: A multicenter international study. Eur J Cancer. 2024 Mar;199:113542.; https://hdl.handle.net/11351/11058Test

  4. 4
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Hernando-Calvo A Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Vila-Casadesús M, Gonzalez-Medina A, Lo Giacco D, Martin A, Fasani R, Mancuso F, Berche R, Jimenez J, Dienstmann R, Nuciforo P, Seoane J, Vivancos A Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Bareche Y Institut du Cancer de Montréal, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada. Faculty of Pharmacy, Université de Montréal, Montréal, QC, Canada. Abbas-Aghababazadeh F Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. Saavedra O, Brana I, Vieito M, Mirallas O, Saoudi Gonzalez N, Valverde C, Muñoz-Couselo E, Suarez C, Diez M, Élez E, Capdevila J, Oaknin A, Saura C, Macarulla T, Carles Galceran J, Felip E, Tabernero J, Garralda E Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Med;4(10); https://doi.org/10.1016/j.medj.2023.07.006Test; Hernando-Calvo A, Vila-Casadesús M, Bareche Y, Gonzalez-Medina A, Abbas-Aghababazadeh F, Lo Giacco D, et al. A pan-cancer clinical platform to predict immunotherapy outcomes and prioritize immuno-oncology combinations in early-phase trials. Med. 2023 Oct 13;4(10):710-727.e5.; https://hdl.handle.net/11351/10525Test

  5. 5
    دورية أكاديمية

    المساهمون: Á. Quintana, V. Peg, A. Prat, T. Moliné, G. Villacampa, L. Paré, P. Galván, R. Dientsmann, P. Schmid, G. Curigliano, E. Muñoz-Couselo, J. Perez-García, M. Marti, J. Blanco-Heredia, C.D. Anjo, M. Vazquez, L. De Mattos-Arruda, J. Cortés

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33743482; info:eu-repo/semantics/altIdentifier/wos/WOS:000645079600017; volume:148; firstpage:134; lastpage:145; numberofpages:12; journal:EUROPEAN JOURNAL OF CANCER; http://hdl.handle.net/2434/826290Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85102636394

  6. 6
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Matos I, Carles J Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Villacampa G, Berché R, Pedrola A, Viaplana C, Dienstmann R Oncology Data Science (OdysSey) Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Hierro C, Martin-Liberal J, Braña I, Azaro A, Vieito M, Saavedra O, Gardeazabal I, Hernando-Calvo A, Alonso G, Galvao V, Ochoa de Olza M, Ros J, Muñoz-Couselo E, Elez E, Rodon J, Saura C, Macarulla T, Oaknin A, Felip E, Garralda E Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Tabernero J Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Department of Medicine, UVic-UCC, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: European Journal of Cancer;155; https://doi.org/10.1016/j.ejca.2021.05.040Test; Matos I, Villacampa G, Hierro C, Martin-Liberal J, Berché R, Pedrola A, et al. Phase I prognostic online (PIPO): A web tool to improve patient selection for oncology early phase clinical trials. Eur J Cancer. 2021 Sep;155:168–78.; https://hdl.handle.net/11351/7702Test; 000693456000020

  7. 7
    دورية أكاديمية

    المصدر: Schmid, Peter; Lipatov, Oleg; Im, Seock-Ah; Goncalves, Anthony; Muñoz-Couselo, Eva; Lee, Keun Seok; Tamura, Kenji; Testa, Laura; Witzel, Isabell; Ohtani, Shoichiro; Turner, Nicholas; Zambelli, Stefania; Harbeck, Nadia; Andre, Fabrice; Dent, Rebecca; Mejia, Jaime A; Zhou, Xuan; Haiderali, Amin; Nguyen, Allison Martin; Cortes, Javier; Winer, Eric P (2023). Impact of pembrolizumab versus chemotherapy on health-related quality of life in patients with metastatic triple-negative breast cancer: results from the phase 3 randomised KEYNOTE-119 study. European Journal of Cancer, 195:113393.

    وصف الملف: application/pdf

    العلاقة: https://www.zora.uzh.ch/id/eprint/256039/1/ZORA_256039.pdfTest; info:pmid/37976633; urn:issn:0959-8049

  8. 8
    دورية أكاديمية

    المساهمون: Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes (IPC), Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)

    المصدر: ISSN: 1470-2045.

    مصطلحات موضوعية: [SDV.CAN]Life Sciences [q-bio]/Cancer

    العلاقة: hal-03629997; https://hal.science/hal-03629997Test

  9. 9
    دورية أكاديمية

    المساهمون: Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes (IPC), Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)

    المصدر: ISSN: 1470-2045.

    مصطلحات موضوعية: [SDV.CAN]Life Sciences [q-bio]/Cancer

    العلاقة: hal-03629997; https://hal.science/hal-03629997Test

  10. 10